February 25, 2003 - Volume 25 - Issue 4
pp: 4-36

Fix These 20 Key Health Areas, IOM Report Urges

Eastman, Peggy

Oncology Times. 25(4):17-18, February 25, 2003.

That's the word from a new report from the Institute of Medicine. Three of the priority areas relate directly to cancer, and several others relate indirectly. The Agency for Healthcare Research and Quality plans to incorporate these 20 domains into its Congressionally mandated National Health Care Quality Report, to be released later this year.



Biological Targeting Still ‘Horizon of Hope’ Despite Passing Cloud

Hidalgo, Manuel

Oncology Times. 25(4):5-6, February 25, 2003.

Despite some disappointments in research results for targeted therapies, there is every reason to believe the future for tyrosine kinase inhibitors and other “smart” cancer therapies is a bright one, says the Co-Director of the Drug Development Program at Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.


GlaxoSmithKline and Canadian Pharmacies

Clark, Paul

Oncology Times. 25(4):7, February 25, 2003.

LETTERS: GSK announced last month that it would no longer supply prescription drugs to Canadian wholesalers and pharmacies that export medicines outside Canada, saying that ordering medicines over the Internet puts patients at risk. The CEO of a large pharmacy in Canada explains why he believes the consequences of this action are potentially grave, especially for cancer patients in the US.

Background: Statement from GlaxoSmithKline

Oncology Times. 25(4):7-8, February 25, 2003.

LETTERS: GSK announced last month that it would no longer supply prescription drugs to Canadian wholesalers and pharmacies that export medicines outside Canada, saying that ordering medicines over the Internet puts patients at risk. The CEO of a large pharmacy in Canada explains why he believes the consequences of this action are potentially grave, especially for cancer patients in the US.





Nomograms: Tailored Prognostic Computer Program Further Validated In International Arena

Henkel, Gretchen

Oncology Times. 25(4):20-21, February 25, 2003.

Nomograms—computer models designed to predict outcomes after treatment for prostate and other cancers—may be a step closer to widespread use now that one of them has been corroborated in a large international study. This issue's Abstract Tracker follows the course of the study.


Optimizing Management of Early‐Stage Hodgkin's Lymphoma: Combined Modalities, Low‐Dose Involved‐Field RT, Careful Stratification, & New Targeted Therapies May Hold Key to Reducing ...

Henkel, Gretchen

Oncology Times. 25(4):25-27, February 25, 2003.

Unanimity about the best approach to early Hodgkin's lymphoma has been elusive. Studies showing an excess risk of second malignancies have included now-outmoded single modalities, high-dose extended-field radiation, and more toxic chemotherapy. As evidenced by current data, combined modalities, low-dose involved-field radiation, careful stratification of risk groups, and newer targeted therapies may hold the key to safer treatment.





1 2 3 4 5